Disability Multiple scales (0 to 100) Short‐term · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Disability (intermediate‐term) RMDQ. Scale from: 0 to 24. · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Adverse events · patients with non‐specific acute and subacute low back pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain: intermediate‐term · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Disability 1 week (immediate term) (RMDQ 0 to 24) · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Disability (intermediate‐term) RMDQ. Scale from: 0 to 24. · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Adverse events · patients with non‐specific acute and subacute low back pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain intensity various scales short‐term · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Pain: intermediate‐term · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Disability Multiple scales (0 to 100) Short‐term · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
Disability (intermediate‐term) RMDQ. Scale from: 0 to 24. · patients with non‐specific acute and subacute low back pain
1 finding from 1 review
All‐cause mortality: range 1 mo to 1 y · adults admitted to the ICU
It is very uncertain whether higher changes all‐cause mortality: range 1 mo to 1 y compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
Proportion of participants with 1 or more serious adverse events according to International Conference on Harmonisation Good Clinical Practice (ICH‐GCP) · adults admitted to the ICU
It is very uncertain whether higher changes proportion of participants with ≥ 1 serious adverse events according… compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
Quality of life (any measure): range 180 d to 1 y · adults admitted to the ICU
1 finding from 1 review
Lung injury diagnosed after randomisation (composite outcome): range 4 d to 23 d · adults admitted to the ICU
It is very uncertain whether higher changes lung injury diagnosed after randomisation (composite outcome): range… compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
Myocardial infarction · adults admitted to the ICU
It is very uncertain whether higher changes myocardial infarction diagnosed after randomisation: range ≤ 90 d compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
Stroke · adults admitted to the ICU
It is very uncertain whether higher changes stroke diagnosed after randomisation: range 1 mo to 3 mo compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
Sepsis diagnosed after randomisation: range 28 d to 60 d · adults admitted to the ICU
It is very uncertain whether higher changes sepsis diagnosed after randomisation: range 28 d to 60 d compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
Wasting · healthy, full‐term (37 to 42 weeks), formula‐fed infants
1 finding from 1 review
Overweight · healthy, full‐term (37 to 42 weeks), formula‐fed infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found